These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17556186)

  • 21. Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs.
    Chinushi M; Hasegawa K; Iijima K; Furushima H; Izumi D; Sato A; Aizawa Y
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):e226-30. PubMed ID: 21418245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization.
    Aizawa Y; Chinushi M; Hasegawa K; Naiki N; Horie M; Kaneko Y; Kurabayashi M; Ito S; Imaizumi T; Aizawa Y; Takatsuki S; Joo K; Sato M; Ebe K; Hosaka Y; Haissaguerre M; Fukuda K
    J Am Coll Cardiol; 2013 Sep; 62(11):1015-9. PubMed ID: 23747791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
    Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infant case with a malignant form of Brugada syndrome.
    Suzuki H; Torigoe K; Numata O; Yazaki S
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1277-80. PubMed ID: 11083249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome.
    Takigawa M; Noda T; Shimizu W; Miyamoto K; Okamura H; Satomi K; Suyama K; Aihara N; Kamakura S; Kurita T
    Heart Rhythm; 2008 Nov; 5(11):1523-7. PubMed ID: 18984526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
    Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cycle length characteristics differentiating non-sustained from self-terminating ventricular fibrillation in Brugada syndrome.
    Cismaru G; Brembilla-Perrot B; Pauriah M; Zinzius PY; Sellal JM; Schwartz J; Sadoul N
    Europace; 2013 Sep; 15(9):1313-8. PubMed ID: 23419658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
    Shinohara T; Ebata Y; Ayabe R; Fukui A; Okada N; Yufu K; Nakagawa M; Takahashi N
    Heart Rhythm; 2014 Aug; 11(8):1441-5. PubMed ID: 24813378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.
    Nam GB; Ko KH; Kim J; Park KM; Rhee KS; Choi KJ; Kim YH; Antzelevitch C
    Eur Heart J; 2010 Feb; 31(3):330-9. PubMed ID: 19880418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).
    Leshem E; Rahkovich M; Mazo A; Suleiman M; Blich M; Laish-Farkash A; Konstantino Y; Fogelman R; Strasberg B; Geist M; Chetboun I; Swissa M; Ilan M; Glick A; Michowitz Y; Rosso R; Glikson M; Belhassen B
    Isr Med Assoc J; 2018 May; 20(5):269-276. PubMed ID: 29761670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome.
    Omiya T; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Hiratsuka A; Fukuda M; Yoshida M; Matsuzaki M
    J Cardiol; 2012 Jul; 60(1):47-54. PubMed ID: 22445599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.